drugset / Trial / NCT00487578
Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction.
Timeline
- Start
- 2006-10
- Primary completion
- 2009-10
- Completion
- 2009-10
Publications
- Background Baandrup L, Jensen R. Chronic post-traumatic headache--a clinical analysis in relation to the International Headache Classification 2nd Edition. Cephalalgia. 2005 Feb;25(2):132-8. doi: 10.1111/j.1468-2982.2004.00818.x.
- Background Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24 Suppl 1:9-160. doi: 10.1111/j.1468-2982.2003.00824.x. No abstract available.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | naratriptan | Small molecule | 2.5 mg | — |
Indications
No indication recorded.